Placeholder Image

字幕列表 影片播放

  • Professor Kevin Ahern: Happy Monday!

  • Monday, Monday, I have a song I'm writing

  • called Hyundai, Hyundai, I'm sure you can figure out

  • the tune it goes to.

  • Hope everybody had a good weekend.

  • Anyone remember it?

  • Alright, enough silliness.

  • We spent some time last time talking about techniques

  • and today I'm going to spend some additional time

  • talking about some new techniques,

  • some of which I think you'll find very medically relevant.

  • So, hopefully, you'll find this interesting what I have to say.

  • Last time I was talking I finished up

  • talking about polyacrylamide gel electrophoresis

  • and more specifically, I talked about SDS-PAGE and SDS-PAGE

  • is what we use to separate proteins by electrophoresis

  • and those proteins we have to manipulate

  • to make them behave like DNA molecules so we manipulate them

  • so they behave like DNA molecules and the manipulation

  • that we did was that we treated them with SDS.

  • The SDS coated those proteins and it made them lay out flat

  • like rods and the coating gave them a very negative charge

  • and the longer that rod was,

  • the more negative charge it would have.

  • The common question I get, and I got last time was,

  • "Well does that negative charge negate any other charge

  • "that's in that protein?"

  • And the answer is yes it does because there's a lot more of those SDS's

  • on there than there are charged residues within that protein.

  • So that effectively makes that a polyanionic substance

  • meaning there are multiple negative charges.

  • And it's not a perfect technique.

  • Some proteins behave a little anomalously but the vast majority

  • of proteins behave very well in SDS

  • and we can see their molecular sizes.

  • The next figure I want to show you is an example of a protein gel

  • where on both sides of this is called a ladder

  • and a ladder simply is a set of proteins of known size

  • that are there and then you can see a protein being purified

  • at various steps in the purification process

  • and there are various quantities of that protein

  • being present and we can see an estimated size from that.

  • As I noted last time, this technique really isn't useful

  • for isolating a protein that we want to use later,

  • it's more of an analytical technique that tells us

  • how much protein do I have here, what's its size

  • and how pure is it compared to the things

  • I'm trying to purify it away from.

  • That's what SDS-PAGE is very, very useful for.

  • SDS-PAGE as we shall see is very useful when combined

  • with another technique that I'm just getting ready

  • to talk to you about and so I'll do that in just a moment

  • but before I do that I'll remind you of the structure of SDS

  • and no you don't have to draw SDS but this is what it looks like.

  • It's a long chain fatty acid and these are all carbons

  • and hydrogens down here and at the end we've got a sulfate

  • and the sulfate is what gives it

  • the negative charge that is necessary for electrophoresis.

  • Well, as I said, if we combine SDS-PAGE with another technique,

  • we get a really, really powerful technique

  • and it's a powerful technique for studying things like cancer,

  • for studying how drugs work and so forth, so I want to spend

  • a few minutes talking about that because I think

  • it's a pretty cool and fascinating technique.

  • The technique I want to discuss first is called isoelectric focusing.

  • Isoelectric focusing and this technique uses some substances

  • that are interesting in their structure,

  • we don't have to talk really too much about them

  • but suffice it to say that it relies on a mixture of compounds

  • that have varying amounts of charge.

  • Some of them are very, very, very negative

  • and some of them are very, very, very positive

  • and some of them are in between, so we can imagine,

  • for example, that we might have a compound that might

  • have forty negative charges and another compound

  • in our mixture that might have thirty-nine, thirty-eight,

  • thirty-seven, thirty-six negative charges and on the other side,

  • we might have something that has forty positive charges

  • and thirty-nine, thirty-eight, thirty-seven.

  • And so, we've got a complete spectrum of charges

  • that are in this mixture that I have.

  • Well if I take this mixture and I treat it very carefully,

  • and I put it into a tube kind of like the columns

  • that we've been talking about and apply an electrical field

  • to that tube what will happen is that the things

  • that are the most negatively charged will move toward

  • the positive electrode and the things

  • that are the most positively charge

  • will move to the negative electrode.

  • And if I look at that tube when I've finished

  • doing this electrical treatment of the tube

  • what I'll see is that the things that had forty minus

  • will be closest to the end followed by the thirty-nine minus

  • and the thirty-eight minus,

  • the thirty-seven minus, etcetera, etcetera.

  • And in the very middle that's where I'll see things

  • that had a zero charge.

  • Make sense?

  • Okay.

  • So this tube turns out to be really nice

  • because if I take this tube and instead of just putting

  • these compounds in there

  • what if I put my mixture of proteins in there as well.

  • Will they separate according to those charges that are in there?

  • And the answer is yes they will.

  • The proteins that are the most negatively charged

  • will be the closest to the positive electrode and those

  • that are the most positively charged

  • will be closest to the negative electrode.

  • And I'll see a spectrum of proteins across that range.

  • Make sense?

  • Now these tubes have a sort of gelatinous-like material

  • in them so what I've done is I've separated

  • these guys on the basis of charge

  • and in essence what I've done is I've separated

  • them on the basis of their pI's.

  • We don't have to worry about that too much at the moment,

  • but that's basically what I've done.

  • Those that have the lowest pI's are on one side

  • and those with the highest pI's are on the other side.

  • All right, now, why do I tell you that?

  • I tell you that because first of all that technique

  • is a way of separating things by their pI's

  • but more importantly when I combine that technique with SDS-PAGE,

  • I get something really, really cool.

  • So let's imagine we do what I just said, we take that tube,

  • we take our proteins, we mix them we run that electrical current

  • so we separate those guys on the basis of their pI

  • with those with the highest pIs on one side

  • and those with the lowest pIs on the other side

  • and the others, a mixture in between.

  • Now what if we carefully take that tube

  • and I open the tube up and I take that gelatinous material out

  • and I lay it on top of a gel where I'm going to do SDS-PAGE?

  • So I add SDS this material that's in here, I coat it all with negative charges,

  • It's not starting out with negative charges

  • because I haven't put anything on it to start with,

  • I just have the proteins by themselves, I add the SDS to it

  • and then I run the material on that tube downwards

  • and separate on the basis of size.

  • What I've just done is something we describe as 2-dimensional gel

  • electrophoresis, two dimensions.

  • The first dimension separated on the basis of pI

  • and the second dimension separated on the basis of size.

  • This figure schematically shows you what I just described.

  • Here are some proteins that have been separated

  • on the basis of their pI on the top and then we've added SDS

  • and applied them to an SDS-PAGE gel

  • and separated them on the basis of,

  • first on the basis of pI, secondly on the basis of their size.

  • All right, so what do we see?

  • We see this gel if we were to look at the upper left

  • we would see the proteins up in here we would see the proteins

  • that have the most negative charge

  • and are the largest.

  • Down here we would see the ones that have the most negative charge

  • and are the smallest,

  • down here the most neutral charge and the smallest, et cetera.

  • You get the idea as we go across this two dimensional gel.

  • Well, this turns out to be an extraordinarily powerful

  • analytical tool as well.

  • Let me show you what an actual 2-D gel looks like.

  • An actual 2-D gel looks something like this.

  • Wow what a mess, right, what a mess this thing is.

  • Well it turns out this mess is pretty darn cool

  • because this mess in this case was taken from all

  • of the proteins in given cell.

  • I can separate all the proteins

  • and I can decide using a variety of techniques

  • which protein corresponds to which spot.

  • Every protein will have its own unique spot.

  • Right, that's one thing and second, this type of analysis

  • if you're very, very careful is very reproducible.

  • It's very reproducible.

  • So what does this mean?

  • Well, let's imagine I want to study a certain cancer

  • and I want to understand something about that cancer.

  • I might take and let's say I've got liver cancer.

  • I might take some cells from my liver that are not cancerous

  • and I might separate those proteins on a 2-D gel

  • and then I might take that liver tumor that I have

  • and I might take those proteins and apply them to a different 2-D gel

  • and then I would compare the 2-D gels and say which proteins are different?

  • which proteins are being made in the cancer

  • but not being made in the regular cell,

  • which proteins are being made in the regular cell

  • that are not being made in the cancer cell,

  • which proteins are being made more in one than the other

  • or less than one in the other, all kinds of things I can ask

  • but now as the result of this analysis I can understand

  • the complete picture of every protein

  • in a normal cell versus a cancer cell.

  • I'm not restricted to cancer.

  • I could say what happens I've got this new drug

  • that I want to treat people with and I want to understand

  • what affect this drug has on our cells.

  • I take one batch of cells over here, don't treat it with the drug

  • another batch of cells over here,

  • treat it with the drug, do 2-D gel electrophoresis

  • and then ask the question, which proteins are different?

  • That's a really powerful tool, an extraordinarily powerful tool

  • This type of analysis tells us very quickly

  • how we're affecting the expression of proteins inside its cells.

  • Since proteins are the workhorses of cells,

  • we know very, very quickly something about the cancer,

  • something about the treatment,

  • something about your cells versus my cells.

  • Maybe I'm making more of one protein than your cells are.

  • You get the idea.

  • 2-D gel electrophoresis is a very powerful tool.

  • Questions on that, yes up in the top.

  • Very, very good question.

  • His question is, if I take a protein that has quaternary structure

  • and I treat it with SDS, will the subunits come apart.

  • Let's take a vote, how many people think they will come apart?

  • How many people think they won't come apart?

  • Majority rules, the subunits will come apart and there's two reasons.

  • One, hydrophobic interactions can in some cases help stabilize

  • a quaternary structure, but even if the quaternary structure

  • is not being stabilized by those interactions,

  • when the individual subunits themselves unfold,

  • it disrupts completely completely the interactions

  • between the subunits.

  • So, quaternary structure is completely disrupted

  • by SDS treatment.

  • Yes?

  • No, actually that's not true.

  • What he said was, "If it denatures, then the individual strands

  • "are going to run faster than the entire protein."

  • But remember, the same happens in any kind of denaturation.

  • When I know I've got a multi-subunit protein,

  • I know what the individual subunits are.

  • I do not know what the overall structure is.

  • Now, your question is very good because if we want to understand

  • the quaternary structure,

  • we have to use other kinds of analytical techniques

  • to understand that.

  • Sometimes we can be working with a protein and have no idea

  • that it's a dimer, for example.

  • If we just simply do SDS PAGE, we won't know

  • that we've got a dimer of two identical subunits.

  • We have to use other analytical techniques to do that,

  • but you're exactly right.

  • Okay, good questions, yeah?

  • Are you going to have to tell me

  • which spot is which, is that what you're saying?

  • Well, I'm not going to say which protein is that spot,

  • if that is the question, but I might point to something on here,

  • and say where would you find, for example,

  • the largest, most positive proteins?

  • That would be fair.

  • Yeah, yeah?

  • Okay, he says if it is vertical,

  • does gravity have an effect and no it does not and the reason it

  • does not is because the electromotive force that is driving it

  • through there is much stronger than anything gravitational effect it could have.

  • Okay, good questions, so that's 2D gel electrophoresis,

  • kind of cool stuff there.

  • Here's a comparison of normal colon cells versus a tumor.

  • And you can see,

  • here's a protein that's made in fairly small amounts

  • in a normal colon and in a tumor it's made

  • in very abundant amounts.

  • You can also see there's probably a difference here and here,

  • there are some differences we see between them

  • and there are some very powerful computer tools that will do that analysis

  • and say how much darker is this spot than that spot

  • so we can get some pretty good ideas from that.

  • Okay, well hopefully what I've told you last time is that,

  • and hopefully you remember, is that we have to do many steps

  • in purification to get a protein that's ultimately very, very pure.

  • And you might wonder, "Why do we care so much about

  • "getting the protein very, very pure?

  • "Is just fairly pure is that okay?"

  • Well, for some analyses, fairly pure is okay,

  • but for many analyses it's not.

  • So one of the analyses we commonly want to do

  • when we purify a protein is we want to determine its structure.

  • Remember we can't predict it from the computer,

  • so we actually have to determine it and to determine it

  • we have to have absolutely pure protein.

  • Techniques that allow us to do that,

  • I'll briefly mention in a little bit,

  • include nuclear magnetic resonance and X-ray crystallography

  • and I'll say something about those two in a little bit.

  • So those two techniques really require us to have protein

  • that is very, very pure and we can see on this gel

  • the analytical use of SDS-PAGE to help us sort of follow

  • what's happening during the purification process.

  • Here's the material we got out of the cell.

  • Here's after we use salt fractionation,

  • that's something I haven't talked about here,

  • you're not responsible for it but it's another purification step.

  • Here's some ion exchange chromatography.

  • Here's what happened after we did gel,

  • and then finally after we did affinity we got something

  • that looked like this.

  • So we can see our protein started out over here

  • and we finally got it to a place where it was fairly pure.

  • One of the things that we need to do

  • during that purification process is to follow it.

  • We have to follow it.

  • We have to test at each step, where's my protein at?

  • How much of it do I have?

  • Because if I don't do that, I really won't have any idea

  • of how much material I'm working with.

  • Further, I ultimately might like to go back into my cells

  • and determine how much material is in a given cell,

  • how many copies of that protein are found in a given cell.

  • So doing the kinds of analyses we see here in table 3.1

  • are very commonly done by researchers and they are done

  • partly also so they don't throw out the baby with the bathwater.

  • Remember, we're doing a step, let's say, centrifugation,

  • where we have a precipitate and we have a supernatant.

  • If we think all the material we want is in the pellet

  • and all we keep the pellet and throw away the supernatant

  • that water might have had the baby in it,

  • so we don't want to do that.

  • We've got to check everything and make sure that it is there.

  • Well, this scheme shows a purification going through

  • the steps you saw on the last figure and this step

  • in the purification follows the amount of protein we've got.

  • So we started out with a protein where we were able to determine

  • we had 15,000 milligrams, that's 15 grams of protein,

  • that's a lot of protein.

  • And after we fractionated by salt we ended up with 4,600.

  • You might say, "well, why do we lose protein?"

  • We lose protein because we're throwing away things

  • we don't want and hopefully keeping things we do want,

  • that's what we saw in the last gel

  • in fact we saw some of those disappearing.

  • After ion exchange chromatography we had 1,278 milligrams,

  • after gel filtration we had 68.8, and by the very end

  • we had 1.75 but you can recall from that gel

  • about the only thing on that gel was in fact our protein.

  • So out of that whole mixture I got 1.75 milligrams of protein.

  • Now, I have to follow the protein, I have to measure its activity.

  • So that protein most commonly might be an enzyme,

  • how much product does it produce per time, that would be a measure

  • of its activity so I can measure its activity in some unit

  • that I can decide what that is.

  • This 15,000 milligrams of protein had 150,000 units

  • of activity to start with.

  • This mixture I had to start with had a specific activity

  • of 10 units per milligram,

  • simply the number of units divided by the number of milligrams.

  • The yield I had was 100% because I haven't done anything yet,

  • I haven't thrown anything away and my purification level

  • was one because again I haven't done anything to it.

  • By the second step what I see is that I've reduced

  • the total protein by a considerable amount,

  • I've reduced the protein by more than a factor of a third,

  • it's less than a third of what I started with,

  • but I still have a pretty good amount of the units.

  • Now you'll say, "Well how come I don't keep all the units?"

  • Well, no purification technique allows you to keep everything.

  • You're going to lose some as you're going along.

  • So this is pretty good, this is pretty good retention.

  • We can see in fact, well how much retention was it?

  • Well it was 92%,

  • it was equal to the number of units I had here divided

  • by the number of units the units I started with, that's 92%.

  • We can see that the result of my purification helped to increase

  • the specific activity because the specific activity

  • went from 10 units per milligram up here

  • to 30 units per milligram up here,

  • remember this is the units divided by the total milligrams

  • so I've increased the specific activity by a factor of three

  • and my purification, therefore, has increased by a factor of three.

  • If I go all the way down I see I get less and less material

  • and I still lose material by the very end I've got one third

  • of my total activity but look how much junk I've gotten rid of,

  • an awful lot of stuff I don't want,

  • so I've actually done pretty well right here.

  • My retention, my yield was thirty five percent which was this number,

  • 52,500 divided by the 150,000, of course times 100 to get percent

  • and I got thirty-five percent yield, so that was pretty good.

  • My specific activity went through the roof,

  • I went from ten here up to 30,000, and 30,000

  • was units divided by total protein again.

  • So my purification level went up 3,000,

  • I purified this guy 3,000-fold.

  • This is a pretty cool purification that I've done

  • and each step along the way gave me purer and purer protein

  • until I finally got down here to the very end.

  • Okay, questions about that?

  • Yes, Omar?

  • Professor Kevin Ahern: I'm sorry?

  • How do you quantify the purification level?

  • The purification level is equal to the purification

  • at any given step divided by what it was when you started,

  • so it's this 30,000 divided by ten which gives you my 3,000.

  • Yes?

  • Professor Kevin Ahern: Is that a pretty typical?

  • It's going to vary a lot from protein to protein,

  • I'd say this is a pretty good yield.

  • Other questions?

  • Alright, we're going to move from purification

  • to some characterization, I'm going to skip over a few things

  • in characterization, there are some things that your book

  • goes through that are really very old and nobody does anymore

  • so I don't think there's a reason we should mess with them.

  • One of the things I do want to talk about

  • are what are called polypeptide cleavage agents.

  • Polypeptide cleavage agents are substances

  • whether they're chemical or enzymes

  • that can break proteins into pieces.

  • That can break proteins into pieces.

  • You might wonder why you want to do that and the answer

  • to that question is because some of the analytical techniques

  • don't work very well on great big proteins but they work nicely

  • on smaller pieces, we'll talk about one in just a little bit.

  • So being able to break proteins

  • into specific smaller pieces is really helpful.

  • As I said there are some of these compounds

  • that work chemically and some that work enzymatically.

  • I will tell you about some in both categories

  • and one of the more common ones used for chemical cleavage

  • is a compound called Cyanogen bromide and what Cyanogen bromide

  • will do is it will break a protein on the carboxyl side

  • of methionine residues.

  • So we find a methionine in a protein

  • and we look on the carboxyl side of it,

  • that's where that Cyanogen bromide is going to break it.

  • I'm not going to discuss the other chemical agents

  • which means again I am not going to hold you responsible for those

  • but I will talk about some of the enzyme ones

  • because some of the enzyme ones we'll talk about later in the class,

  • trypsin is one of those.

  • Trypsin is one of the easier one to remember.

  • It works on the carboxyl sides of lysine

  • and arginine residues, so it's an enzyme.

  • It's actually an enzyme from our digestive system

  • and that enzyme in our digestive system breaks proteins

  • in the carboxyl side of lysine and arginine residues.

  • Another one we're going to talk about later in the term

  • is thrombin.

  • Thrombin is invloved in the blood-clotting process and thrombin cuts

  • on the carboxyl side of arginine.

  • If I look up here at the carboxyl side of lysine

  • and arginine residues, what do those two

  • have in common, anyone remember?

  • What's that?

  • They have an NH3 plus on their side chain

  • and it turns out, that is, in fact, what they're looking at

  • as they are doing their cleavage.

  • All these enzymes are examining the R group side chain

  • of the amino acids and then cutting appropriately.

  • Chymotrypsin is one we'll talk about,

  • I'm not going to hold you responsible for the specific amino acids

  • but I will note that these tend to be fairly nonpolar

  • and, in this case, they tend to be fairly large sidechains,

  • and we'll talk a little bit more about that later.

  • The last one I'll mention is Carboxypeptidase A

  • and it's a very easy one to remember.

  • It's the only one that cuts on the amino side

  • and it acts like a Pac Man.

  • You are all too young to remember what Pac Man was like

  • but Pac man of course started at one end

  • and he just started chewing, chewing, chewing, chewing in.

  • That's what this guy does.

  • It starts at the carboxyl end and it chews

  • in one amino acid at a time.

  • It says it doesn't work on arginine,

  • lysine, and proline and it actuallydoesn't work very well on those,

  • but for our purposes, we'll say it works on all of them

  • just to make it easy for you.

  • So it starts on the carboxy end

  • and it just starts chewing, chewing, chewing, chewing, chewing.

  • If I leave the Carboxypeptidase A in the presence of a protein

  • it will completely eat the protein down to amino acids

  • and you're probably thinking, 'Will it eat itself?

  • 'Will it eat other Carboxypeptidase As?'

  • And the answer is, yes it will.

  • So proteases all have that property.

  • They don't have any distinction between is this a protease

  • or not a protease and act on it, they will eat up each other as well.

  • Yes?

  • Do these proteins become charged after these reactions?

  • Their charges will not change from what they were,

  • but we can imagine let's say we have a protein

  • that had a charge of plus seven and I might cut it

  • into a protein that has a plus four and a plus three,

  • for example, depending upon where I cut it.

  • So depending on where I cut it I'll make subunits, smaller pieces,

  • that might have individual charges

  • but that total charge is going to be the same.

  • We talked about this guy before, I didn't show you the reaction

  • for it but I talked about DTT

  • lecture before last, and DTT, I will remind you,

  • is a reagent that will reduce disulfide bonds to sulfhydryls.

  • It works like mercaptoethanol does.

  • In fact, it works identically to the way mercaptoethanol does.

  • It just starts out with a different structure

  • but the end result is the same, we get sulfhydryls

  • where we started with disulfides

  • and we see that the Dithiothreitol starts out as sulfhydryls

  • and ends up with disulfides, so DTT works like mercaptoethanol does.

  • Now I want to spend a little time-

  • Well actually before I do that I'll talk about-

  • Obviously you guys know the genetic code is the information

  • inside of cells that tells the cell

  • what sequence of amino acids to put together to make a protein.

  • That information is encoded ultimately in the DNA,

  • the DNA is converted into messenger RNA,

  • we'll talk about that next term but suffice it to say

  • that it is actually way, way easier to determine the sequence

  • of a protein by sequencing the DNA that codes for it

  • than it is to try to find the actual amino acid sequence

  • by breaking down a protein and then analyzing

  • each one of those amino acids.

  • That's the way they used to determine the sequence

  • of a protein and that's some of those older techniques

  • I was talking about that we're not going to discuss.

  • They're very, very tedious, they're very, very time-consuming.

  • To give you an idea to determine the amino acid sequence

  • by analyzing a protein, amino acid by amino acid, might take a month for one protein.

  • The way our DNA sequencing technology is today,

  • we can actually determine the entire genome

  • of an organism, if it's a bacterium, in a day

  • and that would include several thousand proteins, in one day.

  • DNA sequencing really has taken over our analysis of proteins.

  • So, what I want to turn our attention to at the moment

  • is a set of immunological techniques we use to analyze proteins

  • and they're used in combination with SDS-PAGE.

  • So what I'm going to describe is something called

  • Western Blotting and I'm going to come to that

  • in a second and show you.

  • but before I talk about western blotting

  • I need to say a little bit about the tool

  • we use to perform the analysis.

  • The tools we use to perform the analysis in western blotting

  • are antibodies and antibodies are proteins of the immune system.

  • They have a very useful property

  • in that they're designed to bind to things,

  • they're designed to bind to structures and more specifically,

  • they're designed to bind to specific structures.

  • So let's imagine for a moment I'm studying the protein insulin.

  • Insulin is a hormone that is found in our body,

  • and I want to analyze this protein by western blotting

  • which is what we're getting ready to do.

  • In order to do that, I would have to have an antibody

  • that recognized and bound to insulin.

  • I would have to have an antibody that recognized

  • and bound to insulin.

  • Turns out I can make one of those or, more specifically,

  • an organism can make one of those for me.

  • How does that occur?

  • Well, let's say I have a bunch of human insulin that I want to study,

  • I take that human insulin and I inject it into a bunny rabbit.

  • Our immune system is set up so that it recognizes invaders

  • and when it recognizes invaders it synthesizes antibodies

  • that bind to those invaders.

  • Since bunny rabbits don't have human insulin,

  • they have bunny insulin, they see the human insulin

  • as an invader and they start making gobs of antibodies.

  • I got a flu shot last week, somebody shot into my arm

  • a whole bunch of proteins from a flu virus and my immune system

  • is right now is recognizing those and making antibodies

  • against those so that when a real flu comes along,

  • it's going to bind to it and keep me from getting infected.

  • Well this bunny rabbit that's making my insulin

  • does this for a while and then I say,

  • "Okay I can really use those antibodies," and it turns out

  • to be very easy, I take a little of the rabbit's blood

  • and then in that blood contains

  • these antibodies that bind to insulin.

  • I can purify those antibodies

  • and now I've got a very powerful tool.

  • These antibodies will bind to insulin

  • and usually only to insulin, specifically human insulin.

  • And that's step one, we don't need to worry about

  • the various nomenclature, antigens and blah blah blah.

  • Antigen is simply what the antibody binds

  • to and this is what the structure schematically

  • of an antibody looks like.

  • We don't even need to worry about that too much.

  • That's really what it looks like more realistically,

  • instead of schematically.

  • Here is an antibody binding to an antigen.

  • So here's that protein that the antibody recognizes

  • and you can see it binding to it here.

  • I tell you that because this is essential

  • for something we call a western blot.

  • Why do I want to do a western blot?

  • Well, a western blot allows me to not only separate proteins

  • but also identify, in that separation which protein

  • is the one I'm interested in studying.

  • Let's go through the steps here.

  • So I've got a mixture of proteins,

  • I bust open some cells, I say,

  • "I'm interested in knowing how much human insulin

  • "is in these cells, or is there human insulin in these cells?"

  • So I take these proteins, I don't purify them,

  • I just separate them on an SDS-PAGE system.

  • I then take that gel that I've just done

  • and I lay it on top of a membrane.

  • That membrane is specially designed to bind to those proteins

  • that are in the gel.

  • So what I can do is use an electric field

  • and transfer them out of the gel and on to the membranes.

  • So now they become stuck to the membrane and that membrane

  • has all the proteins lined up

  • just like they were in the original gel.

  • Everybody with me?

  • I can take that membrane then and put it into a little Ziploc bag

  • and yes, we do use Ziploc bags for these sorts of things,

  • treat it with some buffer and with an antibody

  • that has been made against that insulin.

  • Well you can imagine what's going to happen.

  • The place where insulin is present in this mixture

  • is where the antibody is going to bind and the other places

  • which don't have insulin, it's not going to bind to.

  • I take out that membrane, I wash it off

  • to get rid of the loose stuff that isn't bound to anything

  • and then I treat it with something that tells me,

  • 'Where are there antibodies?'

  • This can be a color reagent, this could be a light reagent

  • that would make things flash, it doesn't really matter

  • what the reagent is but we're simply asking the question,

  • 'Where do I find antibodies?'

  • I get a color, I get a spot,

  • I get whatever but now I can see where in that original mixture

  • my protein was, I get an indication of how much I might have

  • and consequently I've learned something about insulin

  • in those cells that I was studying.

  • This is true, I can do this essentially for any protein

  • that I want so long as I have an antibody

  • that has been made against it.

  • Yes, question.

  • That's a very good question.

  • How does that antibody recognize that protein

  • if I've treated it with SDS?

  • First of all, it doesn't always.

  • There are sometimes the treatment with SDS

  • will disrupt that and not let that occur

  • but the treatments I'm doing here will,

  • A, partly get rid of the SDS

  • and second, the antibodies will often times recognize

  • the primary sequence, not tertiary structure.

  • So if it recognizes short segments

  • of sequence, those are always present in the protein

  • as long as I can expose them and let the antibody get at them,

  • it will recognize it.

  • It's not perfect, it won't always do that,

  • sometimes you'll do it and it just won't show up

  • but most of the time in fact it will.

  • Good question.

  • Other questions?

  • Clear as mud?

  • Anybody awake?

  • Pop quiz then, right?

  • No, no, no!

  • Alright, the next thing I want to talk about,

  • these are all cool techniques and in fact, as I'm going along,

  • we're seeing these techniques are getting more

  • and more sophisticated and they're actually getting,

  • in many cases, newer as well.

  • What I want to talk about that has really revolutionized

  • our ability to analyze proteins in recent years

  • is a technique called MALDI-TOF Mass-Spectrometry.

  • There's a mouthful of a name.

  • MALDI-TOF has a longer name than I'm going to go through here,

  • but it's a technique that involves proteins

  • within an evacuated chamber

  • that are accelerated by an electrical field.

  • Wow there's a mind-boggling kind of thing for you to think about.

  • What does it look like?

  • What do we do?

  • That's not what it looks like, that's what the result looks like.

  • And that's what the blah blah.

  • Oh, I'm missing my link, oh blast it!

  • What did I do?

  • Alright so I'm going to have to describe it to you.

  • You guys get to visualize, right?

  • Visual learners like to visualize,

  • so you guys are going to be visual learners,

  • you're going to visualize this.

  • Let's imagine I have a protein that I want to determine

  • the molecular weight of.

  • A protein's a pretty big thing.

  • A protein might have a molecular weight of 200,000

  • and I told you some techniques don't work real well on large proteins

  • so I have to break it into pieces

  • and I might take a piece of a protein

  • and analyze the molecular weight of that piece.

  • Maybe it has a weight of 8,000,

  • much easier for me to handle.

  • How would I determine what it's mass is?

  • Well MALDI-TOF allows me to do that surprisingly precisely.

  • Surprisingly precisely.

  • How do I do it?

  • Well, I take my protein and I put it into a little crystal

  • and I put it like on the head of a pin.

  • You with me so far, I got my protein it's in a crystal,

  • it's on the head of a pin.

  • This crystal I can volatilize very easily with a laser

  • meaning I shoot it with a laser,

  • it turns into vapor very quickly.

  • Well, if the crystal turns into vapor you can imagine

  • what happens to the protein, it's no longer bound by the crystal.

  • So I've got this crystal, I've got this protein,

  • it's on the head of a pin and I now take this head of a pin

  • and I stick it into an evacuated chamber meaning it's a vacuum,

  • envision that, I have this long tube,

  • I've put my stuff in at one end.

  • Here in there is the head of a pin,

  • it's got this crystal and it's got my protein in it.

  • Then this tube is set up,

  • A, it has no air in it so it's completely evacuated,

  • B, at the other end there is an electrical plate

  • meaning that I can generate an electrical field in here,

  • three, it's got a laser in there.

  • So, here's what I do.

  • I shoot the pin head with the laser,

  • the material volatilizes and that's time zero.

  • When the laser hits the pin, I have time zero.

  • I turn on the electrical field and what happens

  • when the laser hits the material?

  • The protein volatilizes in the chamber

  • now floating and the protein is going to be charged.

  • It turns out that ionizing a protein

  • when I shoot the laser at it,

  • it causes the protein to gain a charge,

  • it starts out with zero charge and it's gaining a charge.

  • My electrical field, now I have a negative here

  • and here I have a positive, guess what's going to happen,

  • it's going to be pulled by the positive-negative interaction.

  • It turns out that the time it takes to move

  • from where it starts to hitting the plate

  • is related to its molecular weight.

  • The MALDI-TOF, when I talk about MALDI-TOF the TOF stands

  • for Time Of Flight.

  • How long does it take to go from here over to here.

  • Each time it has a charge of plus one.

  • Let's see I have something that has a molecular weight of 8,000

  • and it has a charge of plus one,

  • it's going to move at a certain rate, right?

  • Let's say I compare that with something with a molecular weight

  • of 4,000 and a charge of plus one,

  • which one is going to move faster?

  • The smaller one, the weight to mass ratio is smaller

  • so therefore the smaller one will move twice as fast.

  • If it had 16,000 it would move half as fast.

  • Yes?

  • We can set it up so it has a positive or negative,

  • so we don't really need to worry about that,

  • but for our purposes we'll say it has a positive.

  • So now what's happened is by measuring the time it takes

  • I can very precisely measure the molecular weight,

  • and I can even do more really cool things with that

  • because it turns out that when I hit it with the laser

  • several things happen to it.

  • One of the things that happens to it is

  • that big 8,000 molecular weight piece

  • doesn't stay 8,000 molecular weight,

  • it frequently breaks into smaller and smaller and smaller pieces.

  • If I measure the mass of each of those pieces

  • I can actually determine the sequence of the protein.

  • How so?

  • Well, here's a protein that has a sequence of glutamic acid,

  • glutamic acid, glycine, methionine, arginine.

  • If I measure the whole thing it has a mass of 621.

  • If I lose one from this end,

  • I lose a glutamic acid, I know the weight of glutamic acid that's lost

  • the difference between this and this is glutamic acid

  • and only glutamic acid will have that mass.

  • I know it had a glutamic acid.

  • Next it loses another one, next it loses a glycine,

  • next it loses a methionine, you get the idea.

  • I can look at the weight of all those fragments

  • that are in there and say, "Oh, here's the sequence of my protein."

  • It's a really cool way and a really fast way

  • to determine the sequence of a protein

  • if that's what I need to do.

  • Now you might think, that's kind of tedious.

  • It is very tedious, it's computer intensive,

  • very computer intensive.

  • However, if it's set up properly I can determine the sequence

  • of 4,000 proteins a day using this technique,

  • that's why I'm not telling you about the old stuff.

  • 4,000 proteins a day using this technique

  • because the computer just does it automatically.

  • There's a little robot that will punch,

  • I'll take a 2D gel and I'll take one of those spots

  • and a little robot will take this spot

  • and put it in the mass spec

  • and this spot and put it in the mass spec

  • and this spot and put it in the mass spec, each time determining

  • the sequence of each one as it goes along, a really cool technique.

  • So, MALDI-TOF allows us

  • to do some phenomenal analysis of molecular weight.

  • Questions about that?

  • Everybody's kind of blown away by that.

  • You guys look tired today, should we do a song and then finish early?

  • I just had a feeling, i don't know, I just had this feeling about that.

  • Okay, this is a song, I see people leaving

  • and that's interesting because people who are leaving

  • probably don't want to have extra credit questions I'm guessing.

  • Oh ok, there goes your voice, you're losing your voice.

  • This is a song I wrote for BB 350, but you can substitute 450 and it will still work.

  • It's called, "This Song's for BB 4-5-0."

  • [singing] It's one o'clock and Ahern's talkin'

  • Henderson and Hasselbach and pKa's

  • and Buffers I should know.

  • This song's for BB four five oh.

  • I hope that maybe

  • he'll think the way we

  • wrote our answers

  • wasn't crazy

  • I really need the

  • partial credit-so

  • this song's for BB four five oh!

  • It's really groovy

  • that it improves me

  • watching lectures

  • in Quicktime movies.

  • I really need to

  • go and download those

  • podcasts for BB four five oh!

  • I'm feeling manic

  • I'm in a panic

  • I'd better study

  • my old organic.

  • It has reactions

  • that I need to know.

  • This song's for BB four five oh!

  • I know he said it

  • that's why I dread it

  • 'cause I skipped Friday's

  • extra credit

  • 'twil prob'ly haunt me

  • that lonely zero

  • grade in BB four five oh!

  • It could be steric

  • or esoteric

  • that carbons get so

  • anomeric.

  • I'm too hysteric

  • better let it go.

  • This song's for BB three five oh!

  • [END]

Professor Kevin Ahern: Happy Monday!

字幕與單字

單字即點即查 點擊單字可以查詢單字解釋

B1 中級 美國腔

7. Kevin Ahern的《生物化學--蛋白質純化II》。 (7. Kevin Ahern's Biochemistry - Protein Purification II)

  • 107 1
    Scott 發佈於 2021 年 01 月 14 日
影片單字